Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?

Although different types of therapeutic vaccines against established cancerous lesions in various indications have been developed since the 1990s, their clinical benefit is still very limited. This observed lack of effectiveness in cancer eradication may be partially due to the often deficient immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin Lluesma, Silvia, Graciotti, Michele, Chiang, Cheryl Lai-Lai, Kandalaft, Lana E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313858/
https://www.ncbi.nlm.nih.gov/pubmed/30477198
http://dx.doi.org/10.3390/vaccines6040079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313858/
https://www.ncbi.nlm.nih.gov/pubmed/30477198
http://dx.doi.org/10.3390/vaccines6040079

Ejemplares similares